Green Thumb Industries (GTBIF) Other Non-Current Assets (2019 - 2026)
Green Thumb Industries (GTBIF) posted Other Non-Current Assets of $4.4 million for Q1 2026, up 111.25% on a QoQ basis from $2.1 million in Q4 2025, and up 1.63% year-over-year from $4.4 million in Q1 2025.
Green Thumb Industries (GTBIF) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Green Thumb Industries' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 1.63% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 1.63% YoY) and the FY2025 annual result came in at $2.1 million, down 3.23% from the prior year.
- Other Non-Current Assets was $4.4 million for Q1 2026 at Green Thumb Industries, up from $2.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $4.4 million in Q1 2026 and bottomed at $2.0 million in Q2 2025.
- A 5-year average of $2.8 million and a median of $2.6 million in 2024 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 69.54% in 2025, while the deepest fall reached 21.57% in 2025.
- Green Thumb Industries' Other Non-Current Assets stood at $3.1 million in 2022, then dropped by 16.44% to $2.6 million in 2023, then declined by 15.25% to $2.2 million in 2024, then declined by 3.23% to $2.1 million in 2025, then soared by 111.25% to $4.4 million in 2026.
- Business Quant data shows GTBIF's Other Non-Current Assets at $4.4 million in Q1 2026, $2.1 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 4.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.43 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 4.36 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 2.66 Mn |
| Jun 30, 2022 | 2.79 Mn |
| Mar 31, 2022 | 3.04 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 2.87 Mn |
| Mar 31, 2021 | 2.26 Mn |